ConnectiveRx Activates 1.2 Million Providers Through Clinically Embedded Point-of-Care Network

Read the official Press Release here.

Whippany, N.J. — ConnectiveRx, a leading provider of technology-enabled patient support and access solutions for specialty and branded medications, today announced that its clinically embedded network now reaches 1.2 million providers – including physicians, nurse practitioners, and physician assistants – through direct integrations with electronic health records (EHRs), pharmacies, and health systems nationwide.

The ConnectiveRx network is purpose-built for clinical relevance, delivering the most concentrated access to high-value healthcare professionals (MDs, DOs, NPs, and PAs) in positions of patient access. For pharmaceutical brand teams, this means engaging prescribers at treatment decisions rather than through broad advertising.

Recent brand programs using ConnectiveRx's in-workflow messaging have driven 13–15% higher first-fill rates and stronger patient adherence across key therapeutic areas such as cardiovascular, diabetes, and women's health. This precision delivers superior results by combining prescribing history, patient-chart criteria, and clinical data to target appropriate audiences at optimal moments.

Reaching prescribers in-workflow during patient interactions powers better engagement and adherence because patients follow the direction of their trusted provider. The numbers prove it: 82% of patients value health information from their provider's office, and critically, 80% of providers actively share affordability program details with patients (POCMA). This combination of a trusted messenger and cost solutions has proven to directly drive prescription fill and adherence.

“In the one-to-one space between provider and patient, relevance and respect matter. ConnectiveRx’s intelligent messaging prioritizes clinical appropriateness over heavy branding – providing time-relevant information like dosing guidance, support options, and affordability details that help both provider and patient move forward confidently with treatment,” said ConnectiveRx SVP of Messaging Operations Lisa Prowker.

As oversight of traditional pharmaceutical advertising increases, ConnectiveRx offers a fundamentally different approach. These clinically-embedded communications aren't advertising—they're clinical and tactical decision support integrated into provider workflow. This distinction matters: while consumer-directed promotion faces growing restrictions, data-driven point-of-care information remains essential to patient-provider decision making.